scholarly journals Endoscopic Hemostasis Using an Over-the-Scope Clip For Massive Bleeding After Percutaneous Endoscopic Gastrostomy (PEG) Removal: A Case Report

2021 ◽  
Author(s):  
Sun Young Moon ◽  
Min Kyu Jung ◽  
Jun Heo
Keyword(s):  
Case Report ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Massive Bleeding ◽  
Endoscopic Hemostasis ◽  
Endoscopic Gastrostomy ◽  
Over The Scope Clip

Treatment of chronic hepatitis C virus infection with crushed ledipasvir/sofosbuvir administered through a percutaneous endoscopic gastrostomy tube in a patient with HIV coinfection

2020 ◽  
Vol 78 (1) ◽  
pp. 36-40
Author(s):  
Vanessa Huffman ◽  
Diana C Andrade ◽  
Elizabeth Sherman ◽  
Jianli Niu ◽  
Paula A Eckardt
Keyword(s):  
Case Report ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Fixed Dose ◽  
Pharmacokinetic Data ◽  
Percutaneous Endoscopic Gastrostomy Tube ◽  
Endoscopic Gastrostomy ◽  
Hiv Coinfection ◽  
Peg Tube

Abstract Purpose Ledipasvir/sofosbuvir is an oral combination therapy containing fixed doses of direct-acting antiviral agents indicated for the treatment of hepatitis C virus (HCV) infection. Currently there are limited data on the clinical efficacy of crushed ledipasvir/sofosbuvir administered via feeding tube. Summary This case report discusses the successful treatment of chronic HCV genotype 1b infection with crushed ledipasvir/sofosbuvir administered through a percutaneous endoscopic gastrostomy (PEG) tube in a patient with human immunodeficiency virus (HIV) coinfection and high-grade sarcoma who had severe swallowing difficulties. The patient received crushed ledipasvir/sofosbuvir daily for a total of 12 weeks. At 12 weeks the patient had achieved a sustained virologic response. Conclusion Currently, ledipasvir/sofosbuvir is available only as a tablet, with limited pharmacokinetic data available to guide clinicians on use of the fixed-dose combination medication in crushed form. This case report highlights our experience treating a patient with HCV/HIV coinfection through administration of crushed ledipasvir/sofosbuvir via PEG tube, which we found to be a safe and effective therapeutic option.

Stomal seeding after percutaneous endoscopic gastrostomy in esophageal adenocarcinoma: A case report

2001 ◽  
Vol 33 ◽  
pp. A42
Author(s):  
M. Ballarè ◽  
M. Orsello ◽  
M. Del Piano ◽  
P.I. Occhipinti ◽  
F. Montino ◽  
...  
Keyword(s):  
Case Report ◽  
Esophageal Adenocarcinoma ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Endoscopic Gastrostomy

Gastrocolocutaneous Fistula-Delayed complication of Percutaneous Endoscopic Gastrostomy, Case report

2015 ◽  
Vol 1 (4) ◽  
pp. 116 ◽  
Author(s):  
Inanc Sarici ◽  
Ferhat Kala ◽  
Gokmen Kara ◽  
Neslihan Eskut ◽  
Elif Gundogdu
Keyword(s):  
Case Report ◽  
Percutaneous Endoscopic Gastrostomy ◽  
Endoscopic Gastrostomy ◽  
Delayed Complication
Sign in / Sign up

Export Citation Format

Share Document